Related Experiment Video
Updated: Oct 28, 2025

08:17
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
Published on: June 7, 2015
15.9K
Dose delivery accuracy on helical tomotherapy for 4-dimensional tumor motion - a phantom study
Raghavendra Holla1, David Khanna2, V K Sathiya Narayanan1
1Ruby Hall Clinic, Pune, Maharashtra, India.
Summary
Respiratory motion significantly impacts helical tomotherapy (HT) dose delivery accuracy for lung cancer. Exceeding 5mm motion in the superior-inferior direction reduces the gamma pass rate, compromising treatment effectiveness.
Area of Science:
- Radiation Oncology
- Medical Physics
- Image-Guided Therapy
Background:
- Helical tomotherapy (HT) is advanced for lung cancer treatment due to image guidance and conformal dose delivery.
- Respiratory motion poses a challenge to accurate dose delivery in HT.
- Phantom studies are crucial for evaluating motion effects on radiation therapy.
Purpose of the Study:
- To quantify the impact of respiratory motion on delivered dose accuracy in helical tomotherapy.
- To assess the influence of varying motion amplitudes, directions, and delivery interruptions on treatment fidelity.
Main Methods:
- A dynamic phantom simulating lung tumor motion (COS4 pattern) was used with 4D CT.
- Treatment plans were generated, and film dosimetry with gamma analysis assessed dose accuracy.
- Varied parameters included target motion (superior-inferior, anteroposterior, lateral), breathing cycle time, and delivery interruptions.
Main Results:
- Gamma pass rate (3%, 2mm criteria) significantly decreased from 97.5% to 54.4% with increasing superior-inferior motion (3mm to 8mm).
- Combined motion (S-I 8mm, L-R/A-P 3mm) and three delivery interruptions reduced the gamma pass rate by 74%.
- These findings highlight the sensitivity of HT dose delivery to respiratory motion.
Conclusions:
- The internal target volume (ITV) approach in HT is suitable for shallow breathing (<5mm S-I, <3mm L-R/A-P motion).
- Significant deviations from these limits necessitate careful treatment planning and potentially adaptive strategies.
- Motion management is critical for ensuring accurate dose delivery in HT for lung cancer.

